Atlas FDA

Evolut R, Evolut PRO and Evolut PRO+ Transcatheter Aortic Valves (TAV)s

FDA premarket approval P130021/S077 · decided 2020-06-11

Approval details

PMA number
P130021
Supplement
S077
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Evolut R, Evolut PRO and Evolut PRO+ Transcatheter Aortic Valves (TAV)s
Generic name
Aortic valve, prosthesis, percutaneously delivered
Applicant
Medtronic, Inc.
Date received
2020-05-22
Decision date
2020-06-11
Days to decision
20 days
Decision code
OK30
Product code
NPT
Advisory committee
Cardiovascular
Expedited review
No
Location
Miinneapolis, MN
Statement
Manufacturing site addition for the supplier of the primary packaging component for the Evolut R, Evolut PRO, and Evolut PRO+ Transcatheter Aortic Valves.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
VitalFlow Set with Balance™ Biosurface (K261335)Medtronic, Inc.2026-07-31
Concerto Versa™ Detachable Coil (K261866)Medtronic, Inc.2026-06-24
Elongated One-Piece Arterial (EOPA) 3D™ Arterial Cannulae (K260195)Medtronic, Inc.2026-04-23
Retrograde Coronary Sinus Perfusion Cannulae (K253203)Medtronic, Inc.2026-02-19
Clearview Intracoronary Shunts (K253998)Medtronic, Inc.2026-01-20
Bio-Medicus Life Support Catheter and Introducer (K251831)Medtronic, Inc.2026-01-15
Concerto Versa™ Detachable Coil (K253511)Medtronic, Inc.2026-01-14
C320LBB Delivery System (C320LBBS45), C320LBB Delivery System (C320LBBS48), C320LBB Delivery System (C320LBBL45), C320LBB Delivery System (C320LBBL48) (K253409)Medtronic, Inc.2025-12-19